Senseonics Holdings, Inc. (SENS) Stock Analysis
A live, multi-source view of Senseonics Holdings, Inc. (SENS): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Sector: Healthcare · Industry: Medical Devices · United States · 130 employees · senseonics.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Senseonics Holdings, Inc. (SENS) had a market capitalization of $509.2M (forward -4.9) and a beta of 1.08; the shares traded in a 52-week range of $4.79 – $11.58 (11.5% over the year).
- Market cap
- $509.2M
- Enterprise value
- $429.3M
- Forward P/E
- -4.9
- Price / book
- 5.64
- EPS (trailing)
- $-2.24
- EPS (forward)
- $-1.95
- Payout ratio
- 0.0%
- 52-week range
- $4.79 – $11.58
- 52-week change
- 11.5%
- Beta
- 1.08
- Average volume
- 746,611
- Shares outstanding
- 52.9M
- Short % of float
- 11.36%
- Profit margin
- -225.3%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Senseonics Holdings, Inc. (SENS) last closed at $8.79 (the last completed close before that scan).
Technicals at the scan: RSI 55 (neutral territory), price -3.3% versus its 20-day average, 20-day versus 50-day average spread +31.2%, MACD histogram -0.18.
Sentiment inputs: StockTwits 100% bullish; analyst consensus score 57/100.
Next scheduled company event: in 54 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of SENS; corporate insiders filed 1 buy and 0 sells (1 filer, latest disclosure 2026-08-20). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Douglas A. Roeder (1B/0S). Who is trading what
RapidTradeView pick record
SENS has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Senseonics Holdings, Inc. (SENS) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell SENS.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.